| Followers | 202 |
| Posts | 25627 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Thursday, September 09, 2021 7:36:06 PM
What, Labor Day is just past and you’re already having the next freak out? The time to freak out on the last September delay was some time ago. We are now in another range of dates and before Labor Day seemed unlikely. Right after Labor Day may not coincide with a publication date given to them. And we know manufacturing is not even possibly going to be approved before sometime this month, close to the end of the 3Q.
We do know that TLD can drop at any time, we just do not know when. But there is no guarantee it’s what you expect, so every day you need to assess how long to hold. That is what investing in these tiny companies requires. Each day you assess, are you still on board or not? Complaining on a bulletin board won’t expedite trial results.
Each day, investors in these risky, tiny biotechs need to ask themselves how confident they feel, and, frankly, if they feel lucky…? We’ll do you?
Whatever the decision, each day to hold or sell, that is the investor’s decision. Could have sold at $2.51, sure. But that is not a current option. All you’ve got is today.
I don’t blame other people for my successive decisions to hold, or to sell when I should not have sold. These are purely my decisions.
We do know that TLD can drop at any time, we just do not know when. But there is no guarantee it’s what you expect, so every day you need to assess how long to hold. That is what investing in these tiny companies requires. Each day you assess, are you still on board or not? Complaining on a bulletin board won’t expedite trial results.
Each day, investors in these risky, tiny biotechs need to ask themselves how confident they feel, and, frankly, if they feel lucky…? We’ll do you?
Whatever the decision, each day to hold or sell, that is the investor’s decision. Could have sold at $2.51, sure. But that is not a current option. All you’ve got is today.
I don’t blame other people for my successive decisions to hold, or to sell when I should not have sold. These are purely my decisions.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
